KCI BioTech and its wholly-owned subsidiary,KMQ BioTech are CROs specializing in preclinical efficacy and drugability evaluation for pharmaceutical R&D fields.
The company owns two AAALAC-accredited laboratory animal facilities in Suzhou and Nantong, with a total area of more than 40,000 square meters, which can meet the needs of various types of preclinical research. The company has a full range of laboratory animal platforms including mice, hamsters, guinea pigs, rabbits, cats, dogs, pigs, ferrets and non-human primates, an in vivo pharmacodynamic evaluation platform with 400+ models, an anti-infective research and development service platform……
On October 28, 2024, Ms. Li, the R&D director of Chunhai Biotechnology, came to KCI BioTech and presented us with a bright ban…
On June 7th, all employees of KCI Biotechnology (Suzhou) Co., Ltd. came to the Qionglong Mountain Scenic Area in Suzhou to launch …
June 13th is the long-awaited team building activity day for our KMQ friends. Linjiang in the early morning was still shrouded in …